Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06483945 · ClinicalTrials.gov registry record

Dexcom Continuous Glucose Monitoring System Use in aReal-World, Global Registry (Dexcom Global Registry)

A clinical trial of Diabetes, sponsored by DexCom.

Recruiting
Registry status
5,000
Enrollment target
2
Study locations

NCT06483945 is a study of Diabetes that is actively recruiting participants, run by DexCom. The registered enrollment target is 5,000 participants, above the 3,013-participant average among 338 other Diabetes trials with a reported enrollment target (66% higher). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06483945, a study of Diabetes, is actively recruiting participants, sponsored by DexCom.

RECRUITING
Registry status
5,000 participants
Enrollment target
2
Study locations

Study Summary

"To evaluate the use of the Dexcom CGM System when used according to approved commercial labeling during standard clinical use and its impact on intended users in a real-world setting"

Conditions Studied

Interventions

  • DEVICE Dexcom CGM G6/G6 Pro/G7

Study Locations (2)

Georgia

  • Institute of Endocrinology Diabetes, Health & Hormones - Stockbridge

Nevada

  • Palm Research Center - Las Vegas

Trial Details

FieldValue
Enrollment Target 5,000 participants
Start Date 2024-02-28
Est. Completion 2028-06-30

Sponsor

DexCom

26 total trials

What the Registry Record Tells You About NCT06483945

The ClinicalTrials.gov registry entry for NCT06483945 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 3,013-participant average among 338 other Diabetes trials with a reported enrollment target (66% higher). The listed sponsor is DexCom, which has 26 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Dexcom CGM G6/G6 Pro/G7 is the first listed.

NCT06483945 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Georgia, Nevada.

Frequently Asked Questions

What is clinical trial NCT06483945 about?

NCT06483945 is a clinical study titled "Dexcom Continuous Glucose Monitoring System Use in aReal-World, Global Registry (Dexcom Global Registry)". "To evaluate the use of the Dexcom CGM System when used according to approved commercial labeling during standard clinical use and its impact on intended users in a real-world setting"

What is the current status of trial NCT06483945?

This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2024-02-28. Estimated completion is 2028-06-30.

What conditions does trial NCT06483945 study?

This clinical trial studies the following conditions: Diabetes.

What interventions are being tested in trial NCT06483945?

The interventions under investigation include: Dexcom CGM G6/G6 Pro/G7 (DEVICE).

Who is sponsoring clinical trial NCT06483945?

This trial is sponsored by DexCom, which has 26 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06483945 being conducted?

This trial has 2 study locations across Georgia, Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.